APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma

NCT04643405 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped Company Strategy

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: APG-1387 for Injection
DRUG: Gemcitabine
DRUG: Nab paclitaxel

Sponsor

Ascentage Pharma Group Inc.